GCP
AVNS

GSA Capital Partners’s Avanos Medical AVNS Stock Holding History

GSA Capital Partners’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,802
Closed -$593K – 1707
2025
Q4 		$593K Buy
+52,802
New +$604K 0.05% 699
2025
Q1 		– Sell
-12,114
Closed -$193K – 1643
2024
Q4 		$193K Buy
+12,114
New +$240K 0.01% 1421
2022
Q3 		– Sell
-26,366
Closed -$721K – 1506
2022
Q2 		$721K Buy
+26,366
New +$758K 0.11% 286
2019
Q2 		– Sell
-6,370
Closed -$272K – 1430
2019
Q1 		$272K Buy
+6,370
New +$285K 0.03% 1051
2018
Q4 		– Sell
-19,910
Closed -$1.36M – 1344
2018
Q3 		$1.36M Buy
+19,910
New +$1.28M 0.08% 474
2018
Q1 		– Sell
-8,611
Closed -$398K – 1590
2017
Q4 		$398K Buy
+8,611
New +$396K 0.02% 1058
2017
Q3 		– Sell
-5,425
Closed -$213K – 1588
2017
Q2 		$213K Sell
5,425
-48,478
-90% -$1.83M 0.01% 1475
2017
Q1 		$2.05M Buy
+53,903
New +$2.1M 0.11% 250
2016
Q4 		– Sell
-13,645
Closed -$473K – 1740
2016
Q3 		$473K Buy
+13,645
New +$478K 0.03% 1092
2015
Q3 		– Sell
-34,155
Closed -$1.38M – 1735
2015
Q2 		$1.38M Buy
34,155
+18,155
+113% +$815K 0.05% 634
2015
Q1 		$787K Buy
+16,000
New +$741K 0.03% 1060

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

GSA Capital Partners's AVNS Position: Q1 2026 in Review

GSA Capital Partners sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 52,802 shares — an estimated $593K sold.

GSA Capital Partners first reported a position in AVNS in Q1 2015 and held it in 11 quarters. The position peaked at $2.05M in Q1 2017. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • GSA Capital Partners reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 52,802 Avanos Medical shares in Q1 2026, an estimated $593K.
  • GSA Capital Partners first reported a position in Avanos Medical in Q1 2015 and held it in 11 quarters.
  • GSA Capital Partners's Avanos Medical position peaked at $2.05M in Q1 2017.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.